Unlock stock picks and a broker-level newsfeed that powers Wall Street.
OTC Markets OTCPK - Delayed Quote USD

4DMedical Limited (FDMDF)

Compare
0.3400
0.0000
(0.00%)
At close: April 4 at 4:00:00 PM EDT
Loading Chart for FDMDF
  • Previous Close 0.0000
  • Open 0.3700
  • Bid 0.1125 x --
  • Ask 0.1926 x --
  • Day's Range 0.3700 - 0.3700
  • 52 Week Range 0.3204 - 0.4452
  • Volume 6,000
  • Avg. Volume 0
  • Market Cap (intraday) 153.142M
  • Beta (5Y Monthly) 1.36
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0600
  • Earnings Date Mar 3, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

4DMedical Limited operates as a medical technology company in the United States and Australia. It engages in the medical research technology and development of a non-invasive respiratory imaging solution using four-dimensional imaging. The company also offers X-ray velocimetry lung ventilation analysis software (XV LVAS), a lung airflow imaging software, that provides lung health detail from X-Ray scans; computed tomography lung ventilation analysis software (CT LVAS), an image processing software which operates on CT scans to provide functional lung health detail; XV Scanner, a lung function scanner; and Permetium, a multi-function imaging system for pulmonary investigations. The company was incorporated in 2012 and is based in Carlton, Australia.

4dmedical.com

145

Full Time Employees

June 30

Fiscal Year Ends

Recent News: FDMDF

View More

Performance Overview: FDMDF

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

FDMDF
0.00%
S&P/ASX 200 [XJO] (^AXJO)
6.02%

1-Year Return

FDMDF
17.07%
S&P/ASX 200 [XJO] (^AXJO)
1.36%

3-Year Return

FDMDF
74.05%
S&P/ASX 200 [XJO] (^AXJO)
2.05%

5-Year Return

FDMDF
79.27%
S&P/ASX 200 [XJO] (^AXJO)
51.31%

Compare To: FDMDF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: FDMDF

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    70.53M

  • Enterprise Value

    63.56M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    65.94

  • Price/Book (mrq)

    3.17

  • Enterprise Value/Revenue

    69.73

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -23.32%

  • Return on Equity (ttm)

    -52.37%

  • Revenue (ttm)

    5.86M

  • Net Income Avi to Common (ttm)

    -39.54M

  • Diluted EPS (ttm)

    -0.0600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    15.95M

  • Total Debt/Equity (mrq)

    8.05%

  • Levered Free Cash Flow (ttm)

    -28.41M

Research Analysis: FDMDF

View More

Company Insights: FDMDF

Research Reports: FDMDF

View More

People Also Watch